Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A non-randomized, single-panel, open-label trial to study the safety, tolerability and pharmacodynamics of MK-8892 acute dosing in subjects with moderate to severe pulmonary arterial hypertension

X
Trial Profile

A non-randomized, single-panel, open-label trial to study the safety, tolerability and pharmacodynamics of MK-8892 acute dosing in subjects with moderate to severe pulmonary arterial hypertension

Status: Discontinued
Phase of Trial: Phase I

Latest Information Update: 12 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs MK-8892 (Primary)
  • Indications Pulmonary arterial hypertension
  • Focus Pharmacodynamics
  • Sponsors Merck Sharp & Dohme Corp.
  • Most Recent Events

    • 02 Dec 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 31 Jul 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Aug 2014 to 1 Sep 2014.
    • 01 Nov 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top